Round 4 Immunotherapy - Inpatient Admission

After enjoying a couple weeks of "normalcy" at home, Caroline was admitted to the 6A-floor at Vanderbilt this evening for Part 1 (of 2) of Round 4 (of 6) of Immunotherapy treatment.  Treatment will begin in the morning, and she will be once again be on various drugs for nerve pain and nausea throughout the stay.

Assuming no set backs, and all goes as planned, her next 2 weeks will look like this:

• 5 night inpatient stay for IL-2 Drug (which is used to stimulate the body's immune system)
• 2 night break (rest at home!)
• 5 night inpatient stay for combination of IL-2 Drug and Unituxin Antibody (drug used to target Neuroblastoma cells) 

We expect a very difficult upcoming couple of weeks for Caroline...her body is really worn down and tired from the last 14 months of super intense treatment.  Please pray for her comfort, and for minimal side effects over the next 2 weeks.

Thank you for all the support!!!
The Lantz Family
#ftgf 

#carolinestrong